Pharmaceutical giant GlaxoSmithKline has invested $300 million into home DNA testing company 23andMe,Horror Archives allowing it to develop drugs based on human genetics.
The four-year agreement allows GSK access to 23andMe's vast database to accelerate its drug research and development work.
SEE ALSO: The first 3D, full-color X-rays will weird you outMore than 5 million customers use 23andMe's saliva kit to profile their genes. The kits allow users to uncover insights about their ancestry, other people who share your DNA, as well as discover how much of your DNA is Neanderthal.
"We are excited about this unique collaboration as we know that drug targets with genetic validation have a significantly higher chance of ultimately demonstrating benefit for patients and becoming medicines," Hal Barron, GSK's Chief Scientific Officer and president R&D, said in a statement.
23andMe said it already has a portfolio of "early stage" research programmes, which both companies will look to include in the collaboration.
The first project will be a treatment for Parkinson's disease, which currently is in preclinical development. 80 percent of 23andMe's customers have consented to participate in research, and the company said customers are always in control of their information.
"This collaboration will enable us to deliver on what many customers have been asking for -- cures or treatments for diseases," CEO of 23andMe, Anne Wojcicki, added in a statement.
As noted by Reuters, GSK is not the first drug giant to look at modern genetic data, with rivals Roche and AstraZeneca doing the same.
Staff Picks: Monsters, Monkeys, and Maladies by The Paris ReviewThe One Book Margaret Atwood Recommends to Every WriterPortrait of Our White Mother Sitting at a Chinese Men’s Table by Jennifer TsengConsider the Butt by Heather RadkeThe Joys of the Italian Short Story by Jhumpa LahiriThe Obsessive Fictions of László Krasznahorkai by Dustin IllingworthThe Opera Backstage by Cody DelistratyThe Nobel Prize Was Made for Olga Tokarczuk by Jennifer CroftRedux: Courting Sleep by The Paris ReviewConsider the Butt by Heather RadkeStaff Picks: Metaphors, Messengers, and Melancholy by The Paris ReviewI Was Dilapidated by MaryThe Uncanny Child by Elisa GabbertThe Obsessive Fictions of László Krasznahorkai by Dustin IllingworthThe Perseverance of Eve Babitz’s Vision by Molly LambertA Farewell to Summer by Jennifer CroftJust Enjoy Every Fucking Blessed Breath by Rob TannenbaumEmeric Pressburger’s Lost Nazi Novel by Lucy ScholesA Polyphonic Novel of Midcentury San Francisco by Jessica HagedornBooks Won’t Die by Leah Price New Nextdoor update alerts users who try to post racist language Puppy thieves return dog to little girl, after seemingly feeling bad about the whole thing Amazon's long 7 perfect memes that have helped us survive dating in 2017 These organizers just won big in Virginia. They're coming for your state next. Sony is giving away 'Horizon Zero Dawn' for free on PS4 and PS5 YouTube temporarily demonetizes James Charles' channel over misconduct allegations Chevy pushes out Tesla for 'best EV' in U.S. News awards Google Chrome now lets you link people to highlighted text on a website Snap is selling its unsold Spectacles in London Ellen Page says she was harassed by Brett Ratner and other Hollywood men How to listen to audiobooks: Free apps vs. paid subscriptions KFC sent a painting to that guy who discovered the secret hidden in its Twitter account EV owners can get free ultra 'The Oregon Trail' game gets a millennial version for Oregon tourism 'The Office' stars recall a long Amazon reportedly plans to make drivers double as furniture installers More than a dozen Democratic Socialists won last night in a wave of rose emojis Edward Snowden's NFT 'Stay Free' just sold for over $5 million John Legend pens tribute to English teacher who shaped his career
2.8971s , 8200.3203125 kb
Copyright © 2025 Powered by 【Horror Archives】,Openness Information Network